- Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients
-
Hou J, Gane E, Balabanska R, Zhang W, Zhang J, Lim TH, Xie Q, Yeh CT, Yang SS, Liang X, Komolmit P, Leerapun A, Xue Z, Chen E, Zhang Y, Xie Q, Chang TT, Hu TH, Lim SG, Chuang WL, Leggett B, Bo Q, Zhou X, Triyatni M, Zhang W, Yuen MF
- KMID: 2554426
- Clin Mol Hepatol.
- 2024 Apr;30(2):191-205.
- doi: 10.3350/cmh.2023.0422
Background/Aims: Four-week treatment of linvencorvir (RO7049389) was generally safe and well tolerated, and showed anti-viral activity in chronic hepatitis B (CHB) patients. This study evaluated the efficacy, safety, and pharmacokinetics... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular characterization and phylogenetic analysis of pseudorabies virus variants isolated from Guangdong province of southern China during 2013–2014
-
Fan J, Zeng X, Zhang G, Wu Q, Niu J, Sun B, Xie Q, Ma J
- KMID: 2413137
- J Vet Sci.
- 2016 Sep;17(3):369-375.
- doi: 10.4142/jvs.2016.17.3.369
Outbreaks of pseudorabies (PR) have occurred in southern China since late 2011, resulting in significant economic impacts on the swine industry. To identify the cause of PR outbreaks, especially among... -
- CITED
-
- Close
- SHARE
-
- Close
- Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure
-
Chen L, Dai J, Xie Q, Wang X, Cai W
- KMID: 2529853
- Gut Liver.
- 2022 May;16(3):456-464.
- doi: 10.5009/gnl210449
Background/Aims: Metabolic risk factors could accelerate hepatitis B virus (HBV)-related mortality; however, their impacts on disease severity in HBV-related acute on chronic liver failure (HBV-ACLF) patients remain unexplored. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population
-
Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q, Cheng Y
- KMID: 2427118
- Yonsei Med J.
- 2017 Mar;58(2):305-311.
- doi: 10.3349/ymj.2017.58.2.305
PURPOSE: Evidence on the contribution of genes to the hereditary predisposition to pulmonary arterial hypertension (PAH) is limited. MATERIALS AND METHODS: In this study, we hypothesized that single nucleotide variants in... -
- CITED
-
- Close
- SHARE
-
- Close
- The combination of deoxynivalenol and zearalenone at permitted feed concentrations causes serious physiological effects in young pigs
-
Chen F, Ma Y, Xue C, Ma J, Xie Q, Wang G, Bi Y, Cao Y
- KMID: 1102952
- J Vet Sci.
- 2008 Mar;9(1):39-44.
- doi: 10.4142/jvs.2008.9.1.39
This study was to investigate the effects of the combination of deoxynivalenol (DON) and zearalenone (ZON) on pigs. Twenty-four weaning piglets were divided into a control group fed a diet... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathogenicity of Five Strains of Toxoplasma gondii from Different Animals to Chickens
-
Wang S, Zhao GW, Wang W, Zhang ZC, Shen B, Hassan IA, Xie Q, Yan RF, Song XK, Xu LX, Li XR
- KMID: 2381811
- Korean J Parasitol.
- 2015 Apr;53(2):155-162.
- doi: 10.3347/kjp.2015.53.2.155
Toxoplasma gondii is a protozoan parasite with a broad range of intermediate hosts. Chickens as important food-producing animals can also serve as intermediate hosts. To date, experimental studies on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
-
Liu C, You H, Zeng QL, Wong YJ, Wang B, Grgurevic I, Liu C, Yim HJ, Gou W, Dong B, Ju S, Guo Y, Yu Q, Hirooka M, Enomoto H, Hanafy AS, Cao Z, Dong X, LV J, Kim TH, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Xu C, Dai E, Lan X, Lai C, Liu S, Wang F, Guo Y, Lv J, Zhang L, Wang Y, Xie Q, Shao C, Liu Z, Ravaioli F, Colecchia A, Li J, Teng GJ, Qi X
- KMID: 2563414
- Clin Mol Hepatol.
- 2025 Jan;31(1):105-118.
- doi: 10.3350/cmh.2024.0198
Backgrounds/Aims: Non-invasive models stratifying clinically significant portal hypertension (CSPH) are limited. Herein, we developed a new non-invasive model for predicting CSPH in patients with compensated cirrhosis and investigated whether carvedilol... -
- CITED
-
- Close
- SHARE
-
- Close
